...
首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.
【24h】

PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.

机译:通过纳米沉淀制备的PLGA纳米颗粒:水溶性药物的药物负载和释放研究。

获取原文
获取原文并翻译 | 示例
           

摘要

The nanoprecipitation technique for preparation of nanoparticles suffers the drawback of poor incorporation of water soluble drugs. The aim of this study was therefore to assess various formulation parameters to enhance the incorporation of a water soluble drug (procaine hydrochloride) into poly(dl-lactide-co-glycolide) (PLGA) nanoparticles prepared by this technique. Approaches investigated for drug incorporation efficiency enhancement included the influence of aqueous phase pH, replacement of procaine hydrochloride with procaine dihydrate and the inclusion of excipients: poly(dl-lactide) (PLA) oligomers, poly(methyl methacrylate-co-methacrylic acid) (PMMA-MA) or fatty acids into the formulation. The nanoparticles produced were submicron size (<210 nm) and of low polydispersity. It was found that an aqueous phase pH of 9.3, replacement of procaine hydrochloride with procaine dihydrate and the incorporation of PMMA-MA, lauric and caprylic acid into the formulation could enhance drug incorporation efficiency without the size, morphology and nanoparticle recovery being adversely influenced. For instance changing the aqueous phase pH from 5.8 to 9.3 increased nanoparticle recovery from 65.1 to 93.4%, drug content from 0.3 to 1.3% w/w and drug entrapment from 11.0 to 58.2%. However, the presence of high ratios of lauric acid and procaine dihydrate in the formulation adversely affected the morphology and size of the nanoparticles. Also, PLA oligomers were not considered a feasible approach since it decreased drug entrapment from 11.0 to 8.4% and nanoparticle recovery from 65.1 to 19.6%. Drug release from nanoparticles appears to consist of two components with an initial rapid release followed by a slower exponential stage. This study has demonstrated that formulation variables can be exploited in order to enhance the incorporation of a water soluble drug into PLGA nanoparticles by the nanoprecipitation technique.
机译:用于制备纳米颗粒的纳米沉淀技术具有水溶性药物掺入不良的缺点。因此,本研究的目的是评估各种配方参数,以增强将水溶性药物(盐酸普鲁卡因)掺入通过该技术制备的聚(dl-丙交酯-共-乙交酯)(PLGA)纳米粒子中。研究提高药物掺入效率的方法包括水相pH值的影响,用普鲁卡因二水合物代替盐酸普鲁卡因和包含赋形剂:聚(dl-丙交酯)(PLA)低聚物,聚(甲基丙烯酸甲酯-共-甲基丙烯酸)( PMMA-MA)或脂肪酸加入配方中。产生的纳米颗粒为亚微米尺寸(<210 nm)且具有低多分散性。发现pH为9.3的水相,用普鲁卡因二水合物代替盐酸普鲁卡因以及将PMMA-MA,月桂酸和辛酸掺入制剂中可以提高药物掺入效率,而没有尺寸,形态和纳米颗粒回收率的不利影响。例如,将水相pH从5.8更改为9.3可将纳米颗粒的回收率从65.1增至93.4%,药物含量从0.3至1.3%w / w,药物截留从11.0增至58.2%。然而,制剂中高比例的月桂酸和普鲁卡因二水合物的存在不利地影响了纳米颗粒的形态和尺寸。同样,PLA低聚物也不被认为是可行的方法,因为它将药物截留率从11.0降低到8.4%,纳米颗粒回收率从65.1降低到19.6%。从纳米颗粒释放的药物似乎由两个成分组成,它们最初具有快速释放,随后是较慢的指数阶段。这项研究表明,可以利用配方变量来通过纳米沉淀技术增强水溶性药物向PLGA纳米颗粒中的掺入。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号